What Market Size Is Projected For The Percutaneous Mechanical Circulatory Support Devices Market By 2030?
The percutaneous mechanical circulatory support devices market size has grown strongly in recent years. It will grow from $2.46 billion in 2025 to $2.7 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising cardiovascular disease burden, increasing cardiogenic shock cases, adoption of minimally invasive procedures, ICU care expansion, aging population.
The percutaneous mechanical circulatory support devices market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to AI-assisted cardiac monitoring, growth in complex cardiac interventions, expansion of cath lab procedures, demand for temporary heart support, advanced pump technologies. Major trends in the forecast period include minimally invasive cardiac support, short-term hemodynamic assistance, high-risk pci support devices, rapid deployment cardiac systems, enhanced patient safety designs.
Claim Your Free Report Sample Today:
Which Primary Market Drivers Are Fueling Momentum In The Percutaneous Mechanical Circulatory Support Devices Market?
The increasing incidence of cardiovascular diseases is expected to propel the growth of the percutaneous mechanical circulatory support devices market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. The increasing incidence of cardiovascular diseases can be attributed to factors such as an aging population, unhealthy lifestyle choices, obesity, hypertension, and genetic predisposition. Percutaneous mechanical circulatory support devices are used in cardiovascular diseases to improve cardiac function, reduce heart strain, and support recovery in critical heart conditions. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based public health institute, in 2023, about 1 out of every 6 deaths from cardiovascular diseases was among adults younger than 65 years old, and a total of 919,032 people died from cardiovascular disease, representing 1 in every 3 deaths. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the percutaneous mechanical circulatory support (MCS) devices market.
What Major Market Segments Contribute To Shaping The Overall Framework Of The Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devices market covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
What New Trends Are Beginning To Take Shape Within The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are focusing on developing technologically advanced solutions such as intra-aortic axial-flow devices to enhance patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a type of percutaneous mechanical circulatory support (MCS) device designed to assist heart function by augmenting blood flow from the left ventricle to the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device company, announced the successful first-in-human use of its Aortix pump. This innovative device is designed to prevent acute kidney injury (AKI) in patients undergoing cardiac surgery. Delivered via a catheter in the descending thoracic aorta, the Aortix pump improves renal perfusion while decreasing the heart's workload during surgery. It achieves this by enhancing both renal and systemic perfusion while simultaneously reducing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of delivering up to 5.0 liters of flow per minute, the Aortix pump is intended for temporary use during procedures such as percutaneous coronary interventions (PCI).
Who Are The Established And Emerging Players Expanding Their Footprint In The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.
Get Your In-Depth Percutaneous Mechanical Circulatory Support Devices Market Report Now:
Which Regional Clusters Are Forecasted To Outperform Others In The Percutaneous Mechanical Circulatory Support Devices Market?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment